Article Text
Editor's choice
Highlights from this issue
Statistics from Altmetric.com
There is a point in many neurological ward rounds, arriving at the patient with the complicated undiagnosed neurological disorder, when the question arises—often with uncertainty and a hint of desperation—“Should we try steroids?” Fortunately, help is at hand for a fair number of these patients, as the immunological basis of their illness is being better understood. New autoantibodies are dramatically helping in the diagnosis, and the best approach to treatment is becoming clearer. But what should you do if the antibodies are all negative and the patient has all the features of limbic encephalitis? This question is explored by Sherrini Ahmed and colleagues on page 332 and they come up with some helpful suggestions. …
Other content recommended for you
- Paraneoplastic syndromes: when to suspect, how to confirm, and how to manage
- Personal and workplace psychosocial risk factors for carpal tunnel syndrome: a pooled study cohort
- Association between hormone replacement therapy and carpal tunnel syndrome: a nationwide population-based study
- Peripheral nerve diseases
- Limbic encephalitis and antibodies to Ma2: a paraneoplastic presentation of breast cancer
- Ultrasound for diagnosis of carpal tunnel syndrome: comparison of different methods to determine median nerve volume and value of power Doppler sonography
- Dutch injection versus surgery trial in patients with carpal tunnel syndrome (DISTRICTS): protocol of a randomised controlled trial comparing two treatment strategies
- A prospective study of carpal tunnel syndrome: workplace and individual risk factors
- Workplace and individual risk factors for carpal tunnel syndrome
- Does a carpal tunnel syndrome predict an underlying disease?